About
Program Committee
Continuing Education
Program Agenda
Registration
Hotel
Sponsorship and Exhibits
Awards
960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

Since the inaugural meeting in 1970, the Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management and treatment of headache patients. The 2021 Symposium will include in-person education presented in didactic, case-based, evidence-based, panel and demonstrative formats, with online access available on-demand. A virtual-only option is also available.

Register for the in-person or virtual experience today!

WHO SHOULD ATTEND?

This symposium is designed for general practitioners, internists, pediatricians, neurologists, anesthesiologists, dentists, physical therapists, psychologists, psychiatrists, nurse practitioners, physician assistants, nurses, and other health professionals who treat headache.

HEALTH AND SAFETY

The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event.

All attendees, speakers, and exhibitors are required to be vaccinated against the COVID-19 virus at least 14 days prior to arriving for the Symposium. This does not include recommended booster shots.

When picking up badges, each participant will need to provide proof of vaccination (a vaccine card or a phone picture) with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO). These include Pfizer-BioNTechso cure, Johnson and Johnson’s Janssen, Moderna, AstraZeneca-Oxford, and Sinopharm. If you do not have proof of vaccination during arrival, it could result in delays.

Unvaccinated participants are welcome to still participate in the meeting by registering for the virtual option. Anyone who is registered for in-person attendance and would like to switch to virtual attendance can email AHS at any point.

Masks are required for all participants while inside the meeting space, with the exception of during eating or drinking. Masks are encouraged during outdoor events as well.

Social Distancing will be encouraged and seating during sessions will be spread out to allow for more personal space.

PLENARY PALS PROGRAM

If this is your first time attending the Scottsdale Headache Symposium, sign up for the Plenary Pals program during registration to be paired with an experienced attendee who can help guide you through the agenda and meet with you onsite to make sure your experience is fantastic!

SPECIAL NOTE FOR INDIVIDUALS WITH DISABILITIES

The American Headache Society wishes to take steps to ensure that no individual with disability is excluded, denied services, segregated, or otherwise treated differently because of the absence of auxiliary aids and services. If you need auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Headquarters at 856-423-0043, write to us at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

Scottsdale Program Committee

Co-Chairs

Deborah I. Friedman, MD, MPH, FAHS
UT Southwestern Medical Center
Dallas, Texas
Christine Lay, MD, FAHS
University of Toronto
Toronto, Ontario
Rashmi B. Halker Singh, MD, FAHS
Mayo Clinic Arizona
Phoenix, Arizona

Committee Members

Jessica Ailani, MD, FAHS
Medstar Georgetown University Hospital
Washington, District of Columbia
Stephanie J. Nahas, MD, MSEd, FAHS
Thomas Jefferson University
Philadelphia, Pennsylvania
Meredith Barad, MD
Stanford Pain Management Redwood City, California
Scott Powers, PhD, FAHS
Cincinnati Children’s Hospital
Cincinnati, Ohio
Steven D. Bender, DDS, FAHS
Texas A&M College of Dentistry,
Dallas, Texas
Amynah Pradhan, PhD
University of Illinois at Chicago
Chicago, Illinois
Carrie Dougherty, MD, FAHS
Georgetown Headache Center
Washington, District of Columbia
Matthew S. Robbins, MD, FAHS
Weill Cornell Medicine
New York, New York

 

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

PURPOSE/OBJECTIVE

At the conclusion of the program, participants will be able to:

  • Acquire knowledge in the diagnosis, epidemiology, and treatment of headache disorders for clinical practice and research.
  • Apply cutting-edge treatments for the assessment of outcomes in clinical practice.
  • Develop strategies for the treatment of refractory headaches.
  • Describe the importance of respecting diversity and wellness in creating a healthy work environment.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this Other (live and recorded sessions) activity for a maximum of 46.75* AMA PRA Category 1 credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Subject to change.

INSTRUCTIONS FOR CLAIMING CME

  • Attend the sessions in full for which credit is sought/watch the videos
  • Complete the post-activity evaluation
  • A certificate of completion will be available once the evaluation is submitted

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERICAL SUPPORT

The American Headache Society received funding to support this activity from the following organizations:

TBA

AAFP

Application for CME credit has been filed with the American Academy of Family Physicians (AAFP). Determination of credit is pending.

ABPN

An application for self-assessment credit has been filed with the American Board of Psychiatry and Neurology, Inc (ABPN). Determination of credit is pending.

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

2021 Scottsdale Headache Symposium Program Agenda*

*All presentation titles and times are tentative and subject to change.

THURSDAY, NOVEMBER 18, 2021  
6:30 am – 7:00 am  Sunrise Yoga 
8:00 am – 11:00 am  The Anatomy of Headache and Orofacial Pain: An Interventional Based Cadaver Course* 

*Presented at Mayo Clinic 

Co-chair: Rashmi B. Halker Singh, MD, FAHS 

Co-chair: Marcela Romero Reyes, DDS, PhD, FAHS 

8:00 am – 9:00 am  Arrive at Mayo Clinic and Introduction 
9:00 am – 9:15 am  Anatomy Presentation 

Natalie R. Langley, PhD, D-ABFA  

9:15 am – 9:30 am  Neck Etiologies of Headache  

Steven D. Bender, DDS, FAHS  

9:30 am – 9:45 am  Managing Neck Pain and Headache Through Physical Therapy  

Ali Ladak PT, DPT, PhD

9:45 am – 10:00 am  Q&A Panel Discussion 
10:00 am – 11:00 am  Station to Station Rotations: 

Details of the Atlas-C2 Connection and Location of Greater and Lesser Occipital Nerves  

Facet Joints 

Location and Identification of Nerves and Arteries on Facets, Including Cervical Sympathetic Chain 

Hands-On Discussion with a Physical Therapist 

8:00 am – 11:00 am  Pre-meeting Courses/Special Interest Section Symposium 
  Pre-Course 1: Controversies in Headache Medicine 

Presented by the Headache Cooperative of New England (HCNE) 

Moderator: Rebecca Burch, MD, FAHS 

8:00 am – 8:15 am  Migraine Aura Subtype’s: Are They Actually Different? 

William Renthal, MD, PhD 

8:15 am – 8:30 am  Migraine With and Without Aura: Same or Different? 

Andrea Harriott, MD, PhD 

8:30 am – 8:40 am  Q&A Panel Discussion 
8:40 am – 9:10 am  Is There a Role for Opioids and Butalbital Containing Medications in the Treatment of Headache?  

Yes: Paul B. Rizzoli, MD 

No:  Christopher H. Gottschalk, MD 

9:10 am – 9:20 am  Q&A Panel Discussion 
9:20 am – 9:50 am  Is There a Role for Venous Sinus Stenting for Idiopathic Intracranial Hypertension?   

Yes: Ashu Jadhav, MD, PhD 

No:  Brian McGeeney, MD, MPH, MBA 

9:50 am – 10:00 am  Q&A Panel Discussion 
10:00 am – 10:15 am  Why Cluster Headache Gets Missed  

Lawrence C. Newman, MD, FAHS 

10:15 am – 10:30 am  Does Indomethacin-Unresponsive Hemicrania Continua Exist? 

Elizabeth W. Loder, MD, MPH, FAHS 

10:30 am – 11:00 am  Q&A Panel Discussion 
  Pre-Course 2: Migraine and Vascular Disorders – Beyond Ischemic Stroke 

Co-Presented by the Migraine and Vascular Disease and Women’s Health Special Interest Sections 

Moderators:  Andrea Harriott, MD, PhD; Huma Sheikh, MD 

8:00 am – 8:15 am  Welcome and Introduction 

Andrea Harriott, MD, PhD 

Huma Sheikh, MD 

8:15 am – 8:45 am  Migraine and Myocardial Infarction  

Gretchen Tietjen, MD 

8:45 am – 9: 15 am  Migraine and Arterial dissection  

Huma Sheikh, MD 

9:15 am – 9:45 am  Migraine and Vascular Disorders of Pregnancy Andrea Harriott, MD, PhD 
9:45 am – 10:15 am  Treating Migraine in Women with Vascular Disease 

Jelena Pavlovic MD, PhD 

10:15 am – 11:00 am  The Team-Based Approach; Adding Behavioral Therapy to the Practice 

Dawn Buse, PhD, FAHS 

10:35 am – 11:00 am  Q&A Panel Discussion 
  Pre-course 3: Headache 101 

Moderator: Rebecca Erwin Wells, MD, MPH, FAHS 

Co-moderator:  Dawn C. Buse, PhD, FAHS 

8:00 am – 8:15 am  A Brief History of Headache Medicine Through  

the Ages 

Noah Rosen, MD, FAHS 

8:15 am – 8:30 am  Diagnostic Pearls 

Kathleen B. Digre, MD, FAHS 

8:30 am – 8:45 am  Pathophysiology 

Ana Recober-Montilla, MD, FAHS  

8:45 am – 9:00 am  Acute Treatment 

Matthew S. Robbins, MD, FAHS 

9:00 am – 9:15 am  Migraine Prevention 

Jack D. Schim, MD, FAHS 

9:15 am – 9:30 am  Trigeminal Autonomic Cephalalgias 

Claire Sandoe, MD, MS 

9:30 am – 9:45 am  Pediatric Headache  

Ana Marissa Lagman-Bartolome, MD, FAHS  

9:45 am – 10:00 am  Behavioral Strategies 

Steve M. Baskin, PhD 

10:00 – 10:15 am  Secondary Headache Diagnoses Not to Miss 

Hans-Christoph Diener, MD, PhD  

10:15 am – 11:00 am  Q&A Panel Discussion 
12:00 pm – 5:00 pm  Advanced Course – Most Bothersome Symptoms 

Co-Chairs: Andrew F. Russo, PhD; Stephen D. Silberstein, MD, FAHS 

12:00 pm – 12:05 pm  Introductions 

Andrew F. Russo, PhD 

Stephen D. Silberstein, MD, FAHS 

12:05 pm – 12:45 pm  Optimizing Endpoints in Acute Migraine Trials: 

Lessons Learned from Using MBS as a Coprimary 

Outcome 

Richard B. Lipton, MD, FAHS 

12:45 pm – 1:25 pm  Novel Concepts in Understanding Nausea 

Chuchu Zhang, PhD 

1:25 pm – 2:05 pm  The Vestibular System and Migraine 

Carey D. Balaban, PhD 

2:05 pm – 2:45 pm  The Science of Auditory Hypersensitivities that Lead to Phonophobia 

TBD 

2:45 pm – 3:05 pm  Break 
3:05 pm – 3:45 pm  Cognitive Impairment and the Cerebellum: A  

Possible Bridge to Migraine?  

Krystal L. Parker, PhD 

3:45 pm – 4:25 pm  The Science of Photophobia in Migraine 

Rami Burstein, PhD 

4:25 pm – 5:00 pm  Q&A Panel Discussion 
2:00 pm – 5:00 pm  Advanced Practice Providers – The Bridge  

Moderator: Carol Barch, NP 

2:00 pm – 2:05 pm  Welcome/Introduction 

Carol Barch, NP 

2:05 pm – 2:25 pm  Migraine Epidemiology, Risk Factors, and Diagnosis            

Valerie Lawler, NP   

2:25 pm – 2:45 pm  Migraine Pathophysiology                                                         

Laura Xanders, FNP  

2:45 pm – 3:05 pm         Acute Management                                                                    

Karen Williams, DNP, FNP-BC 

3:05 pm – 3:25 pm         Preventive Management                                                           

Jordan Mast, PA-C  

3:25 pm – 3:45 pm         Behavioral to Procedural Management                               

Denise McGrath, DNP 

3:45 pm – 4:05 pm         Special Considerations for Migraine Management in Women                                      

Annika Ehrlich, NP                

4:05 pm – 4:25 pm         Pediatric Migraine Management                                          

Deanna Duggan, NP 

4:25 pm – 5:00 pm         Q&A Panel Discussion 
5:00 pm – 6:30 pm  Welcome and Exhibitor Reception 
6:30 pm – 7:30 pm  Women in Headache Reception 
6:30 pm – 7:30 pm   New Member/Fellow/Trainee Reception 
FRIDAY, NOVEMBER 19, 2021
6:00 am – 7:00 am  5K Fun Run* 

Sponsored by Runnin’ for Research and Miles for Migraine 

*Separate registration required 

6:30 am – 7:00 am  Sunrise Yoga 
7:00 am – 8:00 am  Continental Breakfast and Exhibits 
8:00 am – 8:15 am  Welcome/Opening Remarks 

Peter J. Goadsby, MD, PhD, FAHS, President 

Co-Chairs, Scottsdale Program Planning Committee: 

Christine L. Lay, MD, FAHS  

Deborah I. Friedman, MD, MPH, FAHS 

Rashmi B. Halker Singh, MD, FAHS 

8:15 am – 10:15 am  Plenary I: The Current State of Headache Medicine 

Moderator: Elizabeth W. Loder, MD, MPH, FAHS 

Co-moderator: Deborah I. Friedman, MD, MPH, FAHS 

8:15 am – 8:30 am  Acute Migraine Update 

Jessica Ailani, MD, FAHS 

8:30 am – 8:45 am  Advances in Migraine Prevention  

Cynthia E. Armand, MD 

8:45 am – 9:00 am  Cluster and TACs: What’s New  

Mark J. Burish, MD, PhD 

9:00 am – 9:15 am  Pathophysiology: Bench to Bedside  

Peter J. Goadsby, MD, PhD, FAHS 

9:15 am – 9:30 am  Pediatric Headache 2021 

Marielle Kabbouche, MD, FAHS 

9:30 am – 9:45 am  Recent Advancements in Integrative Treatments 

Rebecca Erwin Wells, MD, MPH, FAHS 

9:45 am – 10:15 am  Q&A Panel Discussion 
10: 15 am – 10:35 am   Refreshment Break & Exhibits 
10:35 am – 12:35 pm  Plenary II: Beyond Primary Headache  

Moderator: Mia Minen, MD, MPH, FAHS 

Co-moderator: Andrew C. Charles, MD, FAHS 

10:35 am – 10:55 am  Clinical Pearls: Headache After COVID-19 

Deena E. Kuruvilla, MD 

10:55 am – 11:10 am  Visual Snow 

Carrie (Beth) Robertson, MD, FAHS 

11:10 am – 11:25 am  Post Traumatic Headache 

Juliana Vanderpluym, MD, FAHS 

11:25 am – 11:40 am  Vestibular Symptoms and Headache 

Shin C. Beh, MD 

11:40 am – 12:05 pm  Functional Neurological Disorders in Headache Medicine  

Jon Stone, PhD 

12:05 pm – 12:35 pm  Q&A Panel Discussion 
12:45 pm – 2:00 pm  Lunch/Break/Exhibits 
2:00 pm – 2:30 pm  Frontiers in Headache Research Award Lectures 

Recipients TBD 

2:30 pm – 3:00 pm  Plenary III: Steven B. Graff-Radford Award Lectureship 

Moderator:  Marcela Romero Reyes, DDS, PhD, FAHS 

Co-moderator: Steven D. Bender, DDS, FAHS 

Recipient TBD 

3:00 pm – 5:00 pm  Plenary IV: Seeking Enrichment and Meaningfulness in Your Headache Practice  

Moderator:  Niushen Zhang, MD, FAHS 

Co-moderator: Scott W. Powers, PhD, FAHS  

3:00 pm – 3:15 pm  Thriving with Changing Roles in Medicine 

Heidi Beck Schwarz, MD 

3:15 pm – 3:30 pm  Burnout… Say the Word (How to Identify Burnout)  

Dawn C. Buse, PhD, FAHS 

3:30 pm – 3:45 pm  Clinician Advocacy as an Antidote to Burnout 

Lawrence C. Newman, MD, FAHS 

3:45 pm – 4:20 pm  Reigniting (Com)Passion in Medicine 

Agnes Wong, MD, PhD, FRCSC  

Interviewed by Deborah I. Friedman, MD, MPH, FAHS 

4:20 pm – 4:35 pm  Approaching the Challenging Visit 

Stephanie J. Nahas, MD, MSEd, FAHS 

4:35 pm – 5:00 pm  Q&A Panel Discussion 
5:00 pm – 6:00 pm   Exhibits 
6:00 pm – 6:30 pm  Special Interest Section Fair 
6:30 pm – 7:00 pm  Town Hall 
SATURDAY, NOVEMBER 20, 2021  
6:30 am – 8:30 am  Continental Breakfast and Exhibits 
7:00 am – 8:30 am  Plenary V: Cutting Edge: The Future State of Headache Medicine  

Moderator: Kathleen B. Digre, MD, FAHS 

Co-moderator: Christine L. Lay, MD, FAHS 

7:00 am – 7:15 am  (New) Delta Opioid Receptors 

Amynah Pradhan, PhD  

7:15 am – 7:30 am  “New” Romodulation (Neuromodulation)  

Stewart J. Tepper, MD, FAHS 

7:30 am – 7:45 am  New Targets 

Andrew C. Charles, MD, FAHS 

7:45 am – 8:00 am  New Pharmacology 

TBD 

8:00 am – 8:30 am  Q&A Panel Discussion 
8:30 am – 10:00 am  Plenary VI: Diversity, Equity, and Inclusion in Headache Medicine 

Moderators: Rebecca Erwin Wells, MD, MPH, FAHS;  

Cynthia E. Armand, MD 

Co-moderator: Peter J. Goadsby, MD, PhD, FAHS 

8:30 am – 8:45 am  Bias: Effect on Health Care  

David McIntosh, PhD  

8:45 am – 9:00 am  The Impact of Bias on Pain Perception  

Larry “L.C” Charleston, MD, FAHS 

9:00 am – 9:20 am  The Value of Implicit Bias Training 

Quinn Capers, MD  

9:20 am – 9:35 am  Ways to do Better Now 

Elizabeth W. Loder, MD, MPH, FAHS 

9:35 am – 10:00 am  Q&A Panel Discussion  
10:00 am – 10:30 am   Refreshments and Exhibits 
10:30 am – 11:00 am  Plenary VII: Debate – Chicken or the Egg: Sleep and Migraine 

Moderator: Rami Burstein, PhD 

Co-moderator: Stephanie J. Nahas, MD, MSEd, FAHS 

PRO: Richard B. Lipton, MD, FAHS 

CON: Gisela Terwindt, MD, PhD, MSc 

11:00 am – 11:30 am  Women’s Health Science Award Lecture 

Moderators: Deena E. Kuruvilla, MD; Huma Sheikh, MD 

Co-moderator: Rashmi B. Halker Singh, MD, FAHS 

Recipient TBD 

11:30 am – 1:00 pm  Plenary VIII: Women’s Health: The Most Common Questions 

Moderator: Thomas Berk, MD 

Co-moderator: Jessica Ailani, MD, FAHS 

11:30 am – 11:45 am  The Most Common Questions I Get Asked on Headache Neuroimaging in Pregnancy 

Jennifer McVige, MD 

11:45 am – 12:00 pm  The Most Common Questions I Get Asked on Migraine Treatment During Pregnancy and Breastfeeding 

Rebecca Burch, MD, FAHS 

12:00 pm -12:15pm  The Most Common Questions I Get Asked on Migraine and Hormones (Menstrual Migraine, Migraine and Menopause) 

Vincent T. Martin, MD 

12:15 pm – 12:30 pm  The Most Common Questions I Get Asked on Migraine and Stroke in Women 

Gretchen E. Tietjen, MD 

12:30 pm – 1:00 pm  Q&A Panel Discussion 
12:30 pm – 2:00 pm  Lunch/Break/Exhibits 
2:30 pm – 4:15 pm  Concurrent Sessions 
  CS1: Skills Training   

Moderator: Paul G. Mathew, MD, FAHS 

Co-moderator: Deborah I. Friedman, MD, MPH, FAHS 

2:30 pm – 2:45 pm  Neurotoxin Therapy 

Andrew Blumenfeld, MD, FAHS 

2:45 pm – 3:00 pm  Nerve Blocks 

Carrie Dougherty, MD, FAHS  

3:00 pm – 3:15 pm  Oromandibular Exam for the Headache Practitioner 

Steven D. Bender, DDS, FAHS 

3:15 pm – 4:15 pm  Hands-On Demonstration 

Demonstrators: Carrie Dougherty, MD, FAHS; Steven D. Bender, DDS, FAHS; Andrew Blumenfeld, MD, FAHS; Christina Szperka, MD, FAHS; Morris Levin, MD, FAHS; Maureen A. Moriarty, APRN, DNP, FAHS 

  CS2: Science 

Moderator: Andrew F. Russo, PhD 

Co-moderator: Amynah Pradhan, PhD 

2:30 pm – 2:45 pm  Spatial Aspects of Pain Modulation in Adolescents with Migraine  

Hadas Nahman-Averbuch, PhD 

2:45 pm – 3:00 pm  Headache and Negative Affect 

Maggie Waung, MD, PhD  

3:00 pm – 3:15 pm  Anti-CGRP Monoclonal Antibodies in Animal  

Models of mTBI 

Anne-Sophie Wattiez, PhD 

3:15 pm – 3:30 pm  Non-Invasive Vagus Nerve Stimulation in Animal Models of Trigeminal Sensitization 

Paul L. Durham, PhD 

3:30 pm – 3:45 pm  Small Animal Imaging and Migraine 

Samuel Grant, PhD 

3:45 pm – 4:15 pm  Q&A Panel Discussion 
  CS3 Headache 202: Beyond the Basics for Advanced Clinicians  

Moderator: Todd J. Schwedt, MD, MSCI, FAHS 

Co-moderator: Matthew S. Robbins, MD, FAHS  

2:30 pm – 2:45 pm  Chronic Migraine 

Merle L. Diamond, MD 

2:45 pm – 3:00 pm  Chronic Cluster Headache 

Christopher H. Gottschalk, MD, FAHS 

3:00 pm – 3:15 pm  Refractory Pediatric Headache 

Marcy E. Yonker, MD, FAHS 

3:15 pm – 3:30 pm  New Daily Persistent Headache 

Randolph W. Evans, MD, FAHS  

3:30 pm – 4:15 pm  Q&A Panel Discussion 
4:00 pm – 6:00 pm  Concurrent Sessions 
  CS4:  Skills Training 

Moderator: Paul G. Mathew, MD, FAHS 

Co-moderator: Rashmi B. Halker Singh, MD, FAHS  

4:30 pm – 4:45 pm  Neurotoxin Therapy 

Andrew Blumenfeld, MD, FAHS 

4:45 pm – 5:00 pm  Nerve Blocks 

Amaal Starling, MD, FAHS 

5:00 pm – 5:15 pm  Oromandibular Exam for the Headache Practitioner 

Steven D. Bender, DDS, FAHS 

5:15 pm – 6:00 pm  Hands-On Demonstration 

Demonstrators: Amaal Starling, MD, FAHS; Steven D. Bender, DDS, FAHS; Deborah I. Friedman, MD, MPH, FAHS; Andrew Blumenfeld, MD, FAHS; Ana Marissa Lagman-Bartolome, MD, FAHS; Maureen A. Moriarty, APRN, DNP, FAHS 

  CS5: Pediatric Headache 

Moderator: Alexandra C. Ross, PhD  

Co-moderator: Amy Gelfand, MD, FAHS  

4:30 pm – 4:45 pm  School and Headaches in Children and Adolescents – The Impact of COVID-19 

Jessica Gautreaux, MD 

4:45 pm – 5:00 pm  Caring for Children, Adolescents, and Young Adults with Headache: A Focus on Diversity, Equity, and Inclusion 

Hope L. O’Brien, MD, MBA, FAHS 

5:00 pm – 5:15 pm  How the Pandemic Impacts the Management of Headache in Children and Their Families 

Meghan S. Candee, MD, MS 

5:15 pm – 5:30 pm  Biobehavioral Care – Latest Evidence and Interdisciplinary Care in the Time of a Pandemic 

Emily Law, PhD 

5:30 pm – 6:00 pm  Q&A Panel Discussion 
  CS6: Secondary Headache Syndromes: CSF Pressure Disorders 

Moderator: Linda Gray Leithe, MD 

Co-moderator: Christine L. Lay, MD, FAHS 

4:30 pm – 4:45 pm  SIH Clinical Diagnosis 

Deborah I. Friedman, MD, MPH, FAHS 

4:45 pm – 5:00 pm  Imaging in CSF Pressure Disorders 

Linda Gray Leithe, MD  

5:00 pm – 5:15 pm  SIH Treatment: Surgery 

Wouter Schievink, MD 

5:15 pm – 5:30 pm  Neurointerventional Treatment of CSF Pressure Disorders 

Peter Kranz, MD  

5:30 pm – 5:45 pm  IIH Diagnosis  

Kathleen B. Digre, MD, FAHS 

5:45 pm – 6:00 pm  IIH Treatment 

Grant T. Liu, MD 

6:00 pm – 6:30 pm  Q&A Panel Discussion 
7:30 pm – 8:30 pm  Reception 
SUNDAY, NOVEMBER 21, 2021  
6:30 am – 7:30 am  Continental Breakfast 
7:00 am – 8:00 am  Expert Opinions: Pearls for Status Migrainosus and Headache Treatment in the Emergency Department  

Moderator: R. Allan Purdy, MD, FAHS 

Co-moderator: Jennifer Robblee, MD, MSc 

Panelists:  

Hans-Christoph Diener, MD, PhD  

A. Laine Green, MD, MSc, FAHS  

Jessica Kiarashi, MD 

Morris Levin, MD, FAHS 

8:00 am – 10:00 am  Practice Management Session 

Moderator: Brad C. Klein, MD, MBA, FAHS 

Co-moderator: Jessica Ailani, MD, FAHS  

8:00 am – 8:20 am  Telemedicine Best Practices and Billing Updates 

Raissa Villanueva, MD, MPH 

8:20 am – 8:35 am  Starting an Academic Headache Center 

Katherine Hamilton, MD 

8:35 am – 8:50 am  Starting a Medical System-Based Headache Center 

Jaclyn R. Duvall, MD 

8:50 am – 9:05 am  Starting a Private Headache Practice 

Audrey L. Halpern, MD 

9:05 am – 9:20 am  Non-Insurance Practice Models 

Susan Hutchinson, MD 

9:20 am – 10:00 am  Q&A Panel Discussion 
8:00 am – 8:45 am  Journals and Publications 

Moderator: Thomas N. Ward, MD, FAHS 

Co-moderator: Rashmi B. Halker Singh, MD, FAHS  

8:00 am – 8:20 am  HEADACHE® 

Amy Gelfand, MD, FAHS 

8:20 am – 8:40 am  And the Rest… 

R. Allan Purdy, MD, FAHS 

8:40 am – 8:45 am  Q&A Panel Discussion 
8:45 am – 9:15 am  Migraine in the Workplace: AMF GPAC update 

Moderator: Lawrence C. Newman, MD, FAHS  

Co-moderator: Christine Lay, MD, FAHS 

Panelists: 

David W. Dodick, MD, FAHS 

Nim Lalvani, MPH 

9:15 am – 10:00 am  Meditation and Mindfulness: A Practical Approach 

Moderator: Dawn C. Buse, PhD, FAHS 

Panelists: 

Scott W. Powers, PhD, FAHS 

Elizabeth Seng, PhD, FAHS 

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

2021 Scottsdale Headache Symposium® Registration Fees and Information

Registration is now open. Click here to register.

Registration will take place online only. If you need assistance or have multiple attendees from your organization to register, please contact the AHS office at ahshq@talley.com or 856-423-0043.

The registration brochure will be available soon.

Registration Categories and Fees*


Early Bird Rate

Before Oct. 1

Regular Rate

Oct. 1 – Nov. 7

Late/On-site

After Nov. 7

AHS Active Member/Non-member
(MD, DO, PhD, DDS, PharmD)
$450/$650 $500/$725 $750/$975
AHS Associate Member/Non-member
(RN, NP, PA)
$200/$250 $250/$300 $500/$550
AHS Trainee Member/Non-member $150/$200 $150/$200 $400/$400
Active Military Personnel $200 $200 $500
Industry Representative $650.00 $725 $975

Pre-Meeting Course Registration Fees*

Early Bird Rate

Before Oct. 1

Regular Rate

Oct. 1 – Nov. 7

Late/On-site

After Nov. 7

AHS Member Complimentary Complimentary $250
Non-member $200 $250 $400

*Prices are the same for the in-person and virtual experiences


REGISTRATION INFORMATION
In-person registration includes admittance to all educational sessions, (except where noted), the exhibit hall, continental breakfast and refreshment breaks each day, as well as several evening receptions during the event. In-person registration also includes full access to the virtual experience which will be available to registrants until May 2022.

Virtual registration includes full access to the virtual experience only and will be available to registrants until May 2022.


HEALTH AND SAFETY
The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event.

All attendees, speakers, and exhibitors are required to be vaccinated against the COVID-19 virus at least 14 days prior to arriving for the Symposium. This does not include recommended booster shots.

When picking up badges, each participant will need to provide proof of vaccination (a vaccine card or a phone picture) with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO). These include Pfizer-BioNTechso cure, Johnson and Johnson’s Janssen, Moderna, AstraZeneca-Oxford, and Sinopharm. If you do not have proof of vaccination during arrival, it could result in delays.

Unvaccinated participants are welcome to still participate in the meeting by registering for the virtual option. Anyone who is registered for in-person attendance and would like to switch to virtual attendance can email AHS at any point.

Masks are required for all participants while inside the meeting space, with the exception of during eating or drinking. Masks are encouraged during outdoor events as well.

Social Distancing will be encouraged and seating during sessions will be spread out to allow for more personal space.


FORMS OF PAYMENT
Checks are acceptable when registration is submitted by mail or completed onsite at the Scottsdale Headache Symposium. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registrant is responsible for any and all bank charges. Mail to:

American Headache Society
2021 Scottsdale Registration
19 Mantua Road
Mount Royal, NJ 08061

Credit cards are the preferred method of payment. AHS accepts Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration.” Note: registrations paid by credit card may be faxed to 856-432-0082. Keep a copy of your fax transmittal confirmation for your record. If faxing, do not mail the original form, doing so may result in duplicate charges to your credit card.

Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) for additional information on wire transfer payments.

Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Scottsdale Headache Symposium. Please do not send cash or travelers checks through the mail.


GROUP DISCOUNTS
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more from an organization (same location) register for the meeting. Registration for group discounts must be submitted together (by mail or fax) with acceptable form(s) of payment. A discount of $25.00 per attendee (after the first attendee pays full price) will be applied.


LETTERS OF INVITATION
If requested, the AHS will send a personal invitation for participation at the Scottsdale Headache Symposium. This invitation is only meant to assist participants in raising travel funds and obtaining a VISA. This is not a commitment on the part of the AHS to provide any financial support.


CANCELLATION POLICY
Requests must be submitted via email no later than Thursday, October 31, 2021.  Once the cancellation is processed, all fees paid will be refunded. If paid by credit card, please allow up to five business days for the credit to show in your bank account.  THERE WILL BE NO REFUNDS AFTER THE OCTOBER 31 DEADLINE.

Attendees who signed up for the In-person Experience may transfer to the Virtual Experience with no penalty. Substitutions will be accepted until November 5, 2021. For cancellations, substitutions, or experience changes, please contact us at ahshq@talley.com.

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

HOTEL ACCOMMODATIONS

Conference Hotel
JW Marriott Camelback Inn
5402 East Lincoln Drive
Scottsdale, AZ 85253  

The JW Marriott Camelback Inn, located in Scottsdale, AZ, is nestled on 125 acres of naturally landscaped desert where guests can enjoy an authentic southwestern experience.  With traditional southwestern décor, the Inn’s casitas are spread throughout the hotel’s desert landscape and all have balconies or patios. Experience the best of Scottsdale with traditional and modern amenities, just minutes from downtown Phoenix, AZ.  

The group room rate at the JW Marriott Camelback Inn for symposium participants is $299.00 for a single or double room, plus prevailing taxes. Room reservations and rates are available on a first-come, first-served basis until Saturday, October 23, 2021, or until the room block is sold out, whichever comes first. After that date, reservation requests will be based on the hotel’s prevailing rate. All reservations must be guaranteed with a credit card.

Overflow Property
Hilton Scottsdale Resort & Villas
2.6 miles from Camelback Inn
6333 North Scottsdale Road
Scottsdale, AZ 85250
Phone: (480) 948-7750
Direct Line: (480) 947-5400

Please note reservations within the AHS block of rooms are for registered attendees ONLY. Reservations made by non-registrants will not receive the discounted rate. A link and passcode to book a room at the JW Marriott Camelback Inn/Hilton Scottsdale Resort will be in your confirmation email once you have completed meeting registration.

 

Other alternative hotels in the area are listed below (AHS is NOT contracted at these hotels):

Sanctuary Camelback Mountain
0.8 miles from Camelback Inn
5700 East McDonald Drive
Paradise Valley, AZ 85253
Phone: (800) 245-2051

DoubleTree Paradise Valley Resort/Scottsdale
3.7 miles from Camelback Inn
5401 N Scottsdale Rd
Scottsdale, AZ 85250
Phone: (480) 947-5400

The Phoenician
3.7 miles from Camelback Inn
6000 East Camelback Road
Scottsdale, AZ 85251
Phone: (480) 941-8200

960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

Sponsorship and Exhibit Information

We are looking forward to welcoming back our sponsors and exhibits to Scottsdale this Fall.

Learn about all of our exciting sponsorship and exhibiting options in the new Sponsorship and Exhibit Prospectus.

 

NEW SPONSORSHIP OPTIONS FOR 2021:

  • Hospitality Suites: Enjoy a room close to the meeting space to host private meetings or as a lounge for your staff.
  • Headshot Lounge: Put your brand in the spotlight and help attendees take a new professional headshot in our dedicated lounge.
  • Wellness Sponsor: Help attendees start the day on the right foot by sponsoring our new sunrise yoga sessions. This includes a gift of a branded yoga mat that each attendee takes home.
  • Coffee Time: Make sure your message is steaming hot by branding coffee cup sleeves and napkins during one of the coffee and exhibit breaks

Use our Exhibit and Sponsorship portal to select a sponsorship opportunity (booth included) or purchase an exhibit booth without sponsorship. You can also purchase additional sponsorship opportunities.

Book Your Sponsorship or Booth Now

Please be prepared to answer a few more questions this year. The Exhibit Review Committee has made some changes to the review process for both previous and new exhibitors.  For example, if you have a new product or device and have exhibited in the past, you may be asked to submit additional collateral before receiving final approval to exhibit.

INDUSTRY SUPPORTED EVENTS

Add your organization to those sharing research and product news with a Satellite Symposium. We have openings from Thursday to Saturday. These events take place without conflict of other CME sessions and will be advertised in the Final Program.

You can offer a presentation with or without CME (you will be responsible for securing your own CME provider) and choose to serve food in your private room with space for over 100 attendees! You must have an FDA-approved product/service.

Download an Industry Supported Event Application here.

If you would like to hold a private meeting or dinner, please complete the Ancillary Meeting/Event Request Form here.

 

The American Headache Society gratefully acknowledges the support of the 2021 Scottsdale Headache Symposium from our industry supporters:

PLATINUM

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

Biohaven Pharmaceuticals logo

Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases. The Company has two small molecule calcitonin gene-related peptide (CGRP) receptor antagonist product candidates in development, rimegepant and vazegepant, for acute and preventive treatment of migraine. Rimegepant, the lead candidate, is an orally-administered, rapidly dissolving single dose CGRP with a novel mechanism that targets the underlying pathophysiology of migraine without causing vasoconstriction.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so every person can be their best.  Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health.

Teva logo

Teva Pharmaceuticals is a global leader in generic medicines and biopharmaceuticals. Building on more than a century-old legacy, Teva delivers high-quality products to patients in nearly every therapeutic area, has an established presence in generics, specialty, OTC and API, a fully integrated R&D function, strong operational base and global infrastructure and scale.

SILVER

Upsher-Smith logo

BRONZE

AbbVie Medical Affairs
Currax Pharmaceuticals LLC
960x180-Scott-21-banner

2021 Scottsdale Headache Symposium

Nov182021

“Frontiers in Headache Research” Scholarship Award

The American Headache Society announces the availability of “Frontiers in Headache Research” Scholarship Awards to attend the 2021 Scottsdale Headache Symposium, November 18-21, 2021 at the JW Marriott Scottsdale Camelback Inn.

Recipients will be selected based on the quality of their research proposal or study and the potential for the proposal, study or thesis to contribute to the advancement of the field of headache medicine. Applicants must be a headache medicine Fellow, Resident and/or post-doctoral fellow in the US or Canada who is in preparatory, active or completion phase of a basic or clinical research project that is related to headache or cranial nociception. Applicants must not have won an AHS scholarship within the past two years. Past winners within two years are not eligible to apply.

Recipients will receive complimentary meeting registration and a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership, and be eligible to receive a stipend up to $1,000 to cover travel expenses.

Thank you for your interest in the Frontiers in Headache Research Scholarship Award. The application period has passed. Applicants will be notified of final acceptance on or about Monday, September 13, 2021.